Principal Investigator
Jie Jin, MD
79 Qingchun Road, Shangcheng District, Hangzhou, Zhejiang, China
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Other1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Relapsed/Refractory B-cell Malignancies
PrincipalinvestigatorStart date: 2021-01-07
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
79 Qingchun Road, Shangcheng District, Hangzhou, Zhejiang, China
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
3 similar investigators found
Lei Fan
The First Affiliated Hospital with Nanjing Medical University
3 trials
Shared therapeutic areas:
Relapsed/Refractory B-cell Malignancies
Similarity Score30%
Heng Mei, Ph.D&M.D
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
5 trials
Shared therapeutic areas:
Relapsed/Refractory B-cell Malignancies
Similarity Score30%
Shufang Zhang
Haisco Pharmaceutical Group Co., Ltd.
1 trials
Shared therapeutic areas:
Relapsed/Refractory B-cell Malignancies
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Relapsed/Refractory B-cell Malignancies
All 1 trials loaded